Mifepristone: Clinical Trials

168 trials of Mifepristone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

104 completed, 28 terminated, 19 unknown, 7 recruiting. 50 Phase 2, 38 Phase 4, 34 Phase 3, 29 Not applicable, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 250Completed 29, Terminated 11, Recruiting 4, Unknown 4, Active not recruiting 1, Withdrawn 1
Phase 438Completed 23, Terminated 7, Unknown 5, Recruiting 2, Withdrawn 1
Phase 334Completed 21, Unknown 6, Terminated 4, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Not applicable29Completed 21, Terminated 4, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 124Completed 19, Terminated 2, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 14Terminated 2, Completed 1, Unknown 1

Follow Mifepristone: new trials by email Literature Review of Mifepristone trials Research Report on Mifepristone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
200mg mifepristone and 800mg misoprostol - Early Pregnancy Loss
Phase 3Not yet recruitingUniversity of Pennsylvania10002027-07-012026-10-09
Period Pills for Menstrual Regulation: A New Reproductive Health Option
Mifepristone + Misoprostol - Menstrual Regulation, Menstrual Health Intervention
Phase 4RecruitingUniversity of California, San Francisco1002026-06-222026-10-27
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Mifepristone 50 mg - Female Contraception
Phase 3Active not recruitingLeiden University Medical Center6152025-05-022026-06-08
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy Loss
mifepristone and misoprostol, Vacuum Aspiration - Early Pregnancy Loss, Abortion, Spontaneous
Not applicableCompletedHarran University882025-04-012026-06-12
Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage
Letrozole, Mifepristone - Silent Miscarriage
Not applicableNot yet recruitingThe University of Hong Kong8842024-12-062024-12-13
REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism
Mifepristone 1200 mg daily, Placebo - Treatment-resistant PTSD
Phase 2RecruitingChristiaan Vinkers602024-11-152024-11-14
Mifepristone vs Misoprostol
Mifepristone, Misoprostol - Cervical Preparation
Phase 1RecruitingMontefiore Medical Center942024-10-312026-07-24
Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens
Levonorgestrel, Mifepristone - Pregnancy Early, Pregnancy Related
Phase 2 / Phase 3UnknownGynuity Health Projects2862024-07-222024-07-18
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Enzalutamide, Mifepristone, TPC - Metastatic Breast Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center2012023-10-182026-02-25
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
Mifepristone plus one dose Misoprostol, Mifepristone plus two doses Misoprostol - Abortion
Phase 3UnknownPlanned Parenthood League of Massachusetts502023-08-302023-09-05
Mifepristone Outpatient Labour Induction
Mifepristone, Placebo - Labor, Induced
Phase 2RecruitingChelsea and Westminster NHS Foundation Trust4002023-08-252026-08-18
To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
Zoladex, Mifepristone Oral Tablet - Submucous Leiomyoma of Uterus
Not applicableUnknownWomen's Hospital School Of Medicine Zhejiang University2942023-06-012023-06-12
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Mifepristone 300 MG [Korlym], Placebo for mifepristone - Hypercortisolism, Diabetes Mellitus, Type 2
Phase 4CompletedCorcept Therapeutics11132023-03-312025-01-20
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy
Letrozole, Mifepristone - Abortion in First Trimester
Phase 4RecruitingKK Women's and Children's Hospital1442022-11-222025-01-22
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
Mifepristone + 2 doses of misoprostol 800 mcg - Medical Abortion
Phase 4TerminatedGynuity Health Projects232022-10-072023-07-25
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Mifepristone, Misoprostol - Abortion, Second Trimester, PPROM
Phase 4CompletedWashington University School of Medicine302022-07-012026-04-07
Reverse Triple Negative Immune Resistant Breast Cancer
Choline, anti-PD-1 antibody and chemotherapy, Sodium Cromoglicate - Triple-negative Breast Cancer
Phase 2RecruitingFudan University902022-06-302026-10-23
Mifepristone for Labor Induction
Mifepristone, Misoprostol - Induced Vaginal Delivery
Phase 3CompletedStanford University302022-06-272024-07-31
Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone
Micronized Progesterone 600 mg, mifepristone 200 mg, Oral Placebo Tablet - Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone
Early Phase 1CompletedReproductive Health Research Insritute, Chile92022-06-072024-09-27
Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages
Mifepristone, Letrozole - Miscarriage
Phase 3CompletedCalcutta National Medical College and Hospital1202022-05-052026-04-02

Showing 20 of 168. Sign in to see all of them.

Conditions studied

Abortion, Spontaneous (8)  ·  Breast Neoplasms (8)  ·  Depression (8)  ·  Cushing Syndrome (7)  ·  Depressive Disorder, Major (7)  ·  Leiomyoma (7)  ·  Psychotic Disorders (7)  ·  Stress Disorders, Post-Traumatic (7)  ·  ACTH Syndrome, Ectopic (4)  ·  Abortion, Incomplete (4)  ·  Abortion, Missed (4)  ·  Alcoholism (4)  ·  Fetal Death (4)  ·  Pituitary ACTH Hypersecretion (4)  ·  Triple Negative Breast Neoplasms (4)

Sponsors

Gynuity Health Projects (28)  ·  Corcept Therapeutics (19)  ·  Stanford University (9)  ·  University of Chicago (5)  ·  Boston University (4)  ·  Karolinska Institutet (4)  ·  Mediterranea Medica S. L. (3)  ·  University of Pittsburgh (3)  ·  Washington University School of Medicine (3)  ·  Hadassah Medical Organization (2)  ·  Indiana University (2)  ·  Johns Hopkins University (2)  ·  Montefiore Medical Center (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  Planned Parenthood League of Massachusetts (2)

Countries

United States (93)  ·  Netherlands (7)  ·  France (6)  ·  United Kingdom (6)  ·  China (5)  ·  Israel (5)  ·  Tunisia (5)  ·  Vietnam (5)  ·  Georgia (4)  ·  India (4)  ·  Mexico (4)  ·  Nepal (4)  ·  Sweden (4)  ·  Croatia (3)  ·  Cuba (3)

Top investigators

Beverly Winikoff, MD, MPH (17)  ·  Katherine Beebe, PhD (5)  ·  Daniel Grossman, MD (4)  ·  Hillary Bracken, PhD (3)  ·  Jennifer Blum, MPH (3)  ·  Lynnette K Nieman, M.D. (3)  ·  Mitchell D Creinin, MD (3)  ·  Ada Lee, MD (2)  ·  Assaf Ben-Meir, MD (2)  ·  Coleman Gross, MD (2)  ·  Dina Abbas, MPH (2)  ·  Eric J Lenze, MD (2)  ·  Hugh Brent Solvason (2)  ·  Ilana Dzuba, MHS (2)  ·  Julia A Golier, MD (2)

Results publications

PMID 29523415, PMID 25013998, PMID 26507877, PMID 34061352, PMID 17138770, PMID 17157102, PMID 17400850, PMID 17963864, PMID 18555814, PMID 18579510, PMID 19389793, PMID 19922989, PMID 20130470, PMID 21477682, PMID 22048462, PMID 22381604, PMID 22466348, PMID 22682721, PMID 22682768, PMID 23090524, PMID 23577182, PMID 23970725, PMID 24084539, PMID 24220703, PMID 24324590, PMID 24633761, PMID 25224026, PMID 25441015, PMID 25482435, PMID 26121746, PMID 26142620, PMID 26196084, PMID 26600007, PMID 26948184, PMID 27314560, PMID 27352735, PMID 27539053, PMID 27664217, PMID 27741182, PMID 29049861, PMID 29874535, PMID 29890128, PMID 30531561, PMID 31307859, PMID 31775677, PMID 31809439, PMID 32215633, PMID 32305259, PMID 33278280, PMID 33507248

NIH funding

P30CA014599 (2), 2014 (1), 2016 (1), R01AA012602 (1), R01HD042578 (1), R01HD071920 (1), U01AA020890 (1), U10CA032102 (1), ZIADK075121 (1)